Okabena Investment Services’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.13M Hold
8,878
0.22% 71
2025
Q4
$1.08M Hold
8,878
0.21% 73
2025
Q3
$890K Buy
8,878
+2,889
+48% +$260K 0.17% 87
2025
Q2
$497K Buy
+5,989
New +$478K 0.11% 102

Other funds holding XBI

Okabena Investment Services's XBI Position: Q1 2026 in Review

Okabena Investment Services held its State Street SPDR S&P Biotech ETF (XBI) position steady in Q1 2026 at 8,878 shares worth $1.13M. The position accounts for 0.22% of the portfolio, ranked #71.

Okabena Investment Services first reported a position in XBI in Q2 2025 and has held it in 4 quarters since. 814 funds tracked by Wall St. Rank hold XBI as of Q1 2026.

  • Okabena Investment Services held 8,878 shares of State Street SPDR S&P Biotech ETF worth $1.13M as of Q1 2026.
  • Okabena Investment Services left its State Street SPDR S&P Biotech ETF share count unchanged in Q1 2026.
  • State Street SPDR S&P Biotech ETF made up 0.22% of Okabena Investment Services's portfolio in Q1 2026, its #71 holding.
  • Okabena Investment Services first reported a position in State Street SPDR S&P Biotech ETF in Q2 2025 and has held it in 4 quarters since.
  • 814 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2026.

Based on Okabena Investment Services's 13F filing for Q1 2026, filed 15 May 2026.